MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation
Clinical and Molecular Hepatology · 2025
DOI: 10.3350/cmh.2024.1163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, 2025. Verfasst von Tiantian Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College and State Key Laboratory f…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Forkhead Box Protein O1, Cell Cycle Proteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, Basic Research Support Program of Huazhong University of Science and Technology.
Abstract (Originalsprache)
Background/Aims: Hepatocellular carcinoma (HCC) is a highly heterogeneous disease, and abnormal MET expression plays a crucial role in its progression. However, the specific pathogenic mechanisms of MET in HCC have yet to be fully elucidated. This study aimed to uncover the oncogenic mechanisms of MET in HCC and explore potential therapeutic implications.
Methods
Transcriptomic data from the HTVi MET/β-catenin HCC model and GSEA results from TCGA LIHC cohorts were analyzed to identify key genes in HCC development. In vitro assays and in vivo models were used to investigate the role of TRIB3 in HCC progression. Immunofluorescence, co-IP, qRT-PCR, and WB revealed target genes regulated by TRIB3. An AAV8-shTRIB3 construct was developed and we assessed its therapeutic potential.
Results
MET promoted HCC development both in vitro and in vivo by upregulating the oncogenic protein TRIB3. Mechanistically, MET transcriptionally activated TRIB3 via the ERK/SP1 axis. TRIB3 then recruited the E3 ubiquitin ligase COP1, which facilitated the ubiquitination and degradation of the tumor suppressor transcription factor FOXO1. TRIB3-mediated FOXO1 ubiquitination upregulated the expression of MET, CCND1 and TWIST1. In clinical HCC samples, TRIB3 expression was correlated with MET and FOXO1 levels. Liver-specific knockdown of TRIB3 by AAV8-shTRIB3 significantly inhibited MET-driven HCC development.
Conclusions
Our results revealed that TRIB3 and COP1 act as key mediators in MET-driven HCC progression. Targeting the MET-TRIB3-FOXO1 regulatory axis may offer a promising therapeutic strategy to counteract oncogenic signaling and impede HCC advancement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Hua…
- Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital of Tongji Medical College, Huazhong University of Science and…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Basic Research Support Program of Huazhong University of Science and Technology
Zitieren
APA
Wang, T., Rao, D., Fu, C., Sun, Z., Luo, Y., Lu, J., Jin, J., Li, H., Fan, F., Liang, H., Huang, W., & Xia, L. (2025). MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2024.1163
Vancouver
Wang T, Rao D, Fu C, Sun Z, Luo Y, Lu J, et al. MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation. Clinical and Molecular Hepatology. 2025. doi:10.3350/cmh.2024.1163
BibTeX
@article{Wang2025,
author = {Wang, Tiantian and Rao, Dean and Fu, Chenan and Sun, Zhoubin and Luo, Yiming and Lu, Junli and Jin, Jie and Li, Han and Fan, Feimu and Liang, Huifang and Huang, Wenjie and Xia, Limin},
title = {MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation},
journal = {Clinical and Molecular Hepatology},
year = {2025},
doi = {10.3350/cmh.2024.1163}
}
EUVIMED